A double-blind, randomized, placebo-controlled trial of SPI-62 safety and efficacy for the treatment of Cushings syndromeMaria Fleseriu,Irina Bancos,David KatzEndocrine Abstracts(2021)引用 1|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要